DAY 1: 4 May 2018  |  FRIDAY
0730 – 0830 Registration
0830 – 0915  PLENARY 1: DIABETES BEGETS DIABETES: HOW TO BREAK THE VICIOUS CYCLE
0915 – 1000  LAUNCH OF MALAYSIA CLINICAL PRACTICE GUIDELINES ON DIABETES IN PREGNANCY
1000 – 1030  Tea Break
1030 – 1200 SYMPOSIUM
DIABETES IN PREGNANCY ADRENAL OSTEOPOROSIS
PRE-CONCEPTIONAL CARE PRIMARY ALDOSTERONISM: WHAT’S NEW? OSTEOPOROSIS: WHEN SHOULD WE TREAT?
PHAMARCOLOGICAL OPTIONS FOR DIABETES IN PREGNANCY CLINICAL PEARLS IN EVALUATION & MANAGEMENT OF PHAEOCHROMOCYTOMA SHOULD WE TREAT TO TARGET?
ANTEPARTUM & POSTPARTUM CARE IMAGING MODALITIES FOR ADRENAL LESIONS ADVANCES IN MANAGEMENT OF OSTEOPOROSIS
1200 – 1240 MEET THE EXPERT 1
UNDERSTANDING OF THYROID FUNCTION TEST FOR THE GENERALIST A CASE OF SPONTANEOUS HYPOGLYCEMIA HORMONAL REPLACEMENT IN HYPOPITUITARISM
1240 – 1400 CCM Pharmaceuticals Lunch Symposium Servier Lunch Symposium
1400 – 1440 MEET THE EXPERT 2
EVALUATION OF YOUNG HYPERTENSION THYROID AND THE BONE MANAGEMENT OF LONG TERM EFFECTS OF CHILDHOOD CANCER SURVIVAL
1400 – 1610 SYMPOSIUM
OBESITY THYROID GROWTH DISORDERS
NUTRITIONAL INTERVENTION: HOW TO MAKE IT WORK? THYROID DISEASE IN ELDERLY SHORT STATURE: WHEN TO INTERVENE?
PHARMACOLOGICAL THERAPY: WHY IS IT UNDERUSED? RADIOACTIVE IODINE THERAPY VS LONG TERM ANTI THYROID THERAPY PUBERTAL INDUCTION IN ADOLESCENTS: WHEN AND HOW?
SURGICAL APPROACH TO OBESITY SUBCLINICAL THYROID DISEASE: WHAT’S NEW? SHOULD WE DELAY PUBERTY IN SHORT ADOLESCENTS ON RHGH?
1610 – 1640  Tea Break
1640 – 1730  AstraZeneca Tea Symposium
1900 – 2100  MSDDinner Symposium

 

DAY 2: 5 May 2018  |  SATURDAY
0730 – 0830  Novo Nordisk Breakfast Symposium
0830 – 0915  PLENARY 3: EVALUATION OF CUSHING SYNDROME: DIAGNOSTIC PITFALLS
0915 – 1010  PLENARY 4: PRIMARY ALDOSTERONISM: WHAT’S NEW?
1010 – 1040  Tea Break / Poster Presentation
1040 – 1210 SYMPOSIUM
DIABETES MELLITUS PITUITARY DISORDER OF SEX DEVELOPMENT (DSD)
DIABETES & HEART FAILURE – THE IMPLICATIONS PERIOPERATIVE MANAGEMENT IN PITUITARY SURGERY DSD PRESENTING IN ADOLESCENTS
DIABETIC KIDNEY DISEASE: CAN IT BE PREVENTED? PITUITARY APOPLEXY- SURGICAL vs. CONSERVATIVE APPROACH CONGENITAL ADRENAL HYPERPLASIA: CONTROVERSIES IN MEDICAL MANAGEMENT
YOUNG ONSET TYPE 2 DIABETES: A TIME BOMB? RADIOLOGIAL EVALUATION OF SELLAR LESIONS AMBIGUOUS GENITALIA: CONTROVERSIES IN SURGICAL MANAGEMENT AND OUTCOME
1210 – 1250 MEET THE EXPERT 3
THYROID DISEASE IN PREGNANCY EVALUATION OF PITUITARY INCIDENTALOMA: HOW FAR SHOULD WE GO? PEDIATRIC: PERIOPERATIVE MANAGEMENT OF HYPOTHALAMIC-PITUITARY LESIONS
1250 – 1400 Sanofi Aventis Lunch Symposium Boehringer Ingelheim Lunch Symposium
1400 – 1440 MEET THE EXPERT 4
BIO-IDENTICAL HORMONES: FACTS vs MYTH? HORMONAL REPLACEMENT IN RAMADAN HYPERCHOLESTEROLEMIA IN THE YOUNG
1440 – 1610 SYMPOSIUM
 REPRODUCTIVE ENDOCRINOLOGY ENDOCRINE NEOPLASIA YOUNG INVESTIGATOR AWARDS
CLINICAL APPROACH TO HIRSUITISM ADVANCES IN TREATMENT OF NEURODENDOCRINE TUMOR
MALE HYPOGONADISM MULTIPLE ENDOCRINE NEOPLASIA
POLYCYSTIC OVARIAN SYNDROME: NEW INSIGHTS UPDATES IN ADRENOCORTICAL CARCINOMA
1610 – 1640  Tea Break
1640 – 1725 Eli Lilly Tea Symposium MEMS 33rdAnnual General Meeting
1930 – 2130  Medtronic Dinner Symposium

 

DAY 3: 6 May 2018  |  SUNDAY
0730 – 0830  Abbott Laboratories Breakfast Symposium
0830 – 0930 SYMPOSIUM
ADRENAL STEROIDS METABOLIC BONE DISEASE THYROID DISORDERS
ANABOLIC STEROIDS – PROS & CONS CLINICAL APPROACH TO HYPOPHOSPHATEMIA HYPERTHYROIDISM IN CHILDREN
CORTISOL TESTING: HOW, WHAT & WHEN? PRIMARY HYPERPARATHYROIDISM: WHEN TO OPERATE? AUTOIMMUNE THYROIDITIS IN CHILDREN: ARE THEY DIFFERENT FROM ADULTS?
0930 – 1010 MEET THE EXPERT 5
HYPERTHYROIDISM: WHEN TO REFER? CHALLENGING CASES OF METABOLIC BONE DISEASES PEDIATRIC: HYPERTENSION IN CHILDREN, WHEN TO SUSPECT ENDOCRINOPATHY?
1010 – 1040  Tea Break
1040 – 1125  PLENARY 5: EVOLUTION IN THYROID CANCER EVALUATION & MANAGEMENT
1125 – 1210  Zuellig-Pharma (Amgen) Lunch Symposium
1210 – 1230  Closing & MAC 9 Prize-Giving Ceremony
1230 – 1400  Lunch & Adjourn